Emory University has yet another case of a psychiatrist with hidden financial conflicts of interest involving the pharmaceutical industry.
The university’s medical-school dean, Thomas J. Lawley, issued a letter of reprimand to Zachary N. Stowe, a professor of psychiatry, after learning that Dr. Stowe was being paid by GlaxoSmithKline, a manufacturer of antidepressants, at the same time Dr. Stowe was conducting a federally backed study of the use of the drugs in pregnant women, The Wall Street Journal reported today.
To continue reading for FREE, please sign in.
Or subscribe now to read with unlimited access for less than $10/month.
Don’t have an account? Sign up now.
A free account provides you access to a limited number of free articles each month, plus newsletters, job postings, salary data, and exclusive store discounts.
If you need assistance, please contact us at 202-466-1032 or help@chronicle.com.